Standard

Phospholipids to Total Lipids in Very Small VLDL percentage

GALNT2 · rs2281719

Where this position leads

Condition: Cholesterol (LDL, HDL and Total)

rs2281719 Condition: Cholesterol (LDL, HDL and Total) Cholesterol (LDL, HDL and Total) Condition rs2281719 rs2281719 GALNT2

Strength of the evidence

3 / 4

Its strongest genetic-study result is p = 10−132, with 27 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 434,646 British ancestry individuals, 8,796 British Central/South Asian individuals, 6,573 British African individuals.

The effect Each copy of the T allele shifted the measure 0.05 % lower (95% confidence interval 0.05-0.05); p = 2 × 10−132.

Where it sits Chromosome 1, band 1q42.13 — in an intron of GALNT2.

How common each version is

CT
Korean KRGDB
C 74.2% · T 25.8%
Korean Korea4K
C 75.4% · T 24.6%
Korean Korea1K
C 74.7% · T 25.3%
Japanese ToMMo
C 73.5% · T 26.5%
Vietnamese
C 70.8% · T 29.2%
World gnomAD
C 54.7% · T 45.3%
World 1000 Genomes
C 65.6% · T 34.4%
World TOPMed
C 55.9% · T 44.1%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study.

What each result means

C/C No copy of the version the research linked to Phospholipids to Total Lipids in Very Small VLDL percentage. This is the starting point the study compared everyone against.
C/T One copy of the version the research linked to Phospholipids to Total Lipids in Very Small VLDL percentage. That is a smaller link than two copies.
T/T Two copies of the version the research linked to Phospholipids to Total Lipids in Very Small VLDL percentage. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Questions about rs2281719

What is rs2281719?

rs2281719 is a single position in the genome, in or near the GALNT2 gene. Published research associates it with phospholipids to total lipids in very small vldl percentage. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

What conditions is rs2281719 linked to?

On MyGeneLog this position is linked to Cholesterol (LDL, HDL and Total). The research behind each link, and its sources, are set out on that condition page.

Does having rs2281719 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs2281719 come from?

GWAS Catalog, Nature genetics 2025, PMID:41044249. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.

Phospholipids to Total Lipids in Very Small VLDL percentage (rs2281719). MyGeneLog™. https://www.mygenelog.com/variants/rs2281719

← See all variants